For investors looking for equity-like participation with some built-in downside protection, structured "buffer" ETFs have grown in popularity. GMAR, the FT Vest U.S. Equity Moderate Buffer ETF - March, fits this category. Instead of holding stocks directly, the fund relies on options to set clear parameters for returns and losses over a set period. Getting a handle on how the cap and buffer function is key before adding it to a portfolio.
GMAR is an actively managed, non-diversified ETF aimed at delivering defined outcomes linked to U.S. large-cap equities. Its goal is to provide returns, before fees and expenses, that track the price return of the SPDR S&P 500 ETF Trust (SPY) up to a preset upside cap, while offering a buffer on the first 15% of losses over roughly a one-year outcome period.
The fund does not own the underlying S&P 500 stocks outright. It instead holds FLEX Options that reference the S&P 500 ETF Trust, along with cash and short-term collateral such as U.S. government money market instruments to back the options positions. Because it is non-diversified, exposure stays concentrated in this single options-based approach.
Issued by First Trust Advisors L.P. and sub-advised by Vest Financial, LLC, GMAR began trading on the Cboe BZX Exchange on March 17, 2023, with a net expense ratio of 0.85%. The "March" designation points to the annual reset: each outcome period ends around late March, when a new cap and 15% buffer are set for the next year. The 2025–2026 period had an upside cap of 12.20% (before fees and expenses), while an earlier cycle had a cap of 15.30%. These levels shift each year based on options-market conditions. I also checked this using Tickeron’s AI Screener to see how the parameters compare across similar products.
GMAR draws interest because it provides a clear trade-off: participation in U.S. large-cap equity gains up to a cap, paired with protection against the first 15% of losses. This can suit investors who want broad S&P 500 exposure yet remain cautious about steep declines.
The ETF’s sector exposure reflects the diversified makeup of the S&P 500 through its options position, covering technology, financials, healthcare, consumer cyclical, and other major areas. As a result, GMAR serves as a vehicle for broad market access with an added risk-management layer rather than a concentrated industry bet. Its defined-outcome design also appeals to those seeking more predictable return and loss ranges over a known horizon, such as investors approaching a specific financial milestone.
The buffer-and-cap design of GMAR involves clear limitations. The upside cap restricts total returns—if the underlying S&P 500 ETF rises beyond the cap in a given year, investors miss out on the excess. The buffer applies only to the first 15% of losses; any further declines are the investor’s responsibility, after fees. These parameters hold only if the fund is held for the full outcome period; buying or selling mid-cycle produces different and potentially less predictable results.
As an options-based fund, GMAR carries additional considerations. Its 0.85% expense ratio exceeds that of many standard index ETFs. The fund is non-diversified and tied to U.S. large-cap performance, so it remains exposed to overall market risk and does not guard against losses past the buffer. The annual reset also means the available protection and cap depend on the timing of the investment.
In my own research, Tickeron’s AI Screener has proven useful for screening defined-outcome ETFs like GMAR. The platform lets users filter by technical indicators, fundamentals, volatility, trends, AI signals, and custom criteria, making it easier to compare caps, buffers, and reset dates across products. It helps surface ideas that align with a given strategy without replacing individual due diligence.
The FT Vest U.S. Equity Moderate Buffer ETF - March (GMAR) fills a specific role in the ETF space by combining broad U.S. large-cap equity exposure with a structured risk overlay. Its annual upside cap and 15% downside buffer create a tool for investors who value defined outcomes over unlimited participation. By reviewing its strategy, holdings, and reset mechanics, investors can assess whether this approach fits their financial profile and risk tolerance.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.
GMAR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 16 of 24 cases where GMAR's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 67%.
Following a +1.03% 3-day Advance, the price is estimated to grow further. Considering data from situations where GMAR advanced for three days, in 170 of 283 cases, the price rose further within the following month. The odds of a continued upward trend are 60%.
The 10-day RSI Indicator for GMAR moved out of overbought territory on October 13, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 55 similar instances where the indicator moved out of overbought territory. In 13 of the 55 cases, the stock moved lower in the following days. This puts the odds of a move lower at 24%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 14 of 49 cases where GMAR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 29%.
The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GMAR as a result. In 13 of 52 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 25%.
The Moving Average Convergence Divergence Histogram (MACD) for GMAR turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In 11 of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at 28%.
GMAR moved below its 50-day moving average on November 16, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for GMAR crossed bearishly below the 50-day moving average on November 11, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 3 of 6 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 50%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GMAR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 31%.
The Aroon Indicator for GMAR entered a downward trend on November 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.